# OnCo record infinitopes (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/infinitopes/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "infinitopes" ;
  schema:name "Infinitopes"@en ;
  schema:description "Infinitopes is an Oxford company making an off-the-shelf cancer vaccine meant to train the immune system to stop oesophageal cancer coming back after surgery. Its vaccine, ITOP1, was preparing for its first placebo-controlled human trial in 2026."@en ;
  schema:url <https://onco.cc/companies/infinitopes/>, <https://www.infinitopes.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.infinitopes.com/>, <https://www.biospace.com/integrated-cancer-biotech-infinitopes-secures-12-8m-seed-financing-to-enhance-its-precision-immunomics-antigen-discovery-technologies-to-target-five-more-cancers>, <https://european-biotechnology.com/latest-news/oxford-based-cancer-vaccine-company-infinitopes-closes-35-million-seed-round/> ;
  schema:addressCountry "GB" ;
  onco:cancers <https://onco.cc/cancers/esophageal/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/shared-antigen-vaccine/> .
